Related Experiment Videos
[Functional rating scales for amyotrophic lateral sclerosis]
P Couratier1, F Torny, M Lacoste
1Centre SLA, Service de Neurologie, CHU Dupuytren, Limoges. philippe.couratier@unilim.fr
Revue Neurologique
|April 6, 2006
Summary
Amyotrophic lateral sclerosis (ALS) evaluation requires validated scales to track motor function loss and daily life impacts. Clinicians must choose scales based on clinical goals for accurate patient assessment and research.
Area of Science:
- Neurology
- Clinical Assessment
- Motor Neuron Diseases
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons, leading to significant loss of motor function.
- Assessing motor deficits in ALS is crucial for understanding patient progression and impact on daily activities.
- Numerous evaluation scales exist, but standardized recommendations for their use are limited.
Purpose of the Study:
- To review and discuss various scales used for evaluating motor function and disability in Amyotrophic Lateral Sclerosis (ALS) patients.
- To highlight the importance of scale selection based on specific clinical objectives and research needs.
- To inform clinicians about the utility, validity, and limitations of different ALS assessment tools.
Main Methods:
- Systematic review of existing literature on scales for ALS patient evaluation.
- Categorization of scales based on their application: global progression, disease staging, and specific function assessment.
- Analysis of scale characteristics including validation, simplicity, data output, and correlation with clinical outcomes like survival.
Main Results:
- Global scales (e.g., ALSFRS, ALS Severity Scale) effectively track disability progression and correlate with patient survival.
- Scales like the ALS Health State Scale aid in classifying patients into homogeneous stages of disease severity.
- Specific scales (e.g., Sadoul, Borg, Epworth) offer targeted evaluations of particular functions, valuable for detailed assessments.
Conclusions:
- The choice of evaluation scale in ALS depends critically on the clinical objective, ranging from global progression monitoring to specific functional assessments.
- Clinicians must possess a thorough understanding of each scale's validity, sensitivity, specificity, and potential interpretation pitfalls for effective patient management and research.
- Validated, user-friendly scales that yield statistically analyzable results are essential for reliable ALS patient follow-up and clinical research.